Related Experiment Video
Updated: Sep 13, 2025

06:02
Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
186
Same-Day Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement
Quentin Fischer1, Marina Urena2, Guillem Muntané-Carol3
1Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.
JACC. Cardiovascular Interventions
|July 30, 2025
Summary
Same-day permanent pacemaker implantation (PPI) is safe for patients with persistent heart block after transcatheter aortic valve replacement (TAVR). This approach shortens hospital stays without increasing complications, supporting its use in TAVR procedures.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Electrophysiology
Background:
- Conduction disturbances requiring permanent pacemaker implantation (PPI) are a primary complication following transcatheter aortic valve replacement (TAVR).
- Persistent complete or high-degree atrio-ventricular block (CHB/HAVB) after TAVR necessitates careful management strategies.
Purpose of the Study:
- To evaluate the impact of same-day PPI in patients who develop persistent CHB/HAVB during TAVR.
- To compare outcomes between immediate and delayed pacemaker implantation in this patient cohort.
Main Methods:
- A multicenter study involving consecutive patients undergoing TAVR without prior pacemakers.
- Prospective collection of baseline, procedural, and follow-up data, including pacing interrogations.
- Stratification into same-day PPI (SDP) and non-same-day PPI (n-SDP) groups.
Main Results:
- Of 584 patients, 157 (26.9%) received SDP and 427 (73.1%) were observed. 88% of the observed group eventually required PPI.
- The SDP group had a shorter hospitalization length (5 vs. 8 days) with no increase in periprocedural complications.
- One-month follow-up showed similar pacing burdens and pacemaker dependency rates between SDP and n-SDP groups.
Conclusions:
- Same-day PPI is a safe strategy for TAVR patients with persistent CHB/HAVB.
- SDP is associated with reduced hospitalization duration and high pacing burden at 30 days.
- The low rate of conduction recovery in the non-implanted group supports early intervention.

